Clinical Trial Update: Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating selinexor in combination with fludarabine and cytarabine for refractory or relapsed acute myeloid leukemia has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Selinexor (selinexor)
• flu-darabine (fludarabine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2020-04-24